Mortality at one year in post PCI myocardial infarction

Courtesy of Dr. Brian Nazareth Donato.

Mortality at One Year in Post PCI MI Multiple definitions with biomarkers and variable thresholds have been proposed to diagnose post procedural MI. The last update of the Third Universal Definition of Myocardial Infarction decided to use only troponin values with a threshold >5 over the normal value, on top of the clinical evidence by ECG, echocardiography or symptoms of ischemia to differentiate it from myocardial injury. After this last definition, SCAI used troponin thresholds >70 over normal values to define clnically relevant AMI type 4 a.

 

This retrospective study analyzed patients with stable and unstable angina and non ST myocardial infarction from one single institution during one year. These patients received PCI and troponin levels were analyzed before and after procedure. The study assessed mortality, recurrent AMI and repeat revascularization.  

 

Results: of 516 analyzed patients, 53 (10.3%) presented AMI type 4a, 116 (22.5%) myocardial injury (5 fold troponin elevation over normal values) and 347 (67.2%) did not show any significant changes in cardiac marker values, which made them the control group.

 

At one year follow up, there were no clinically significant differences in mortality between the three groups (p=0.13). Recurrent AMI was similar in both AMI 4a and myocardial injury groups, which showed significantly higher values than the control group (p=0.03).

 

Procedural complexity varied between the groups: there was a higher number of stents, longer stent length, more use of rotational atherectomy and more bifurcations treatments in both the AMI 4 a group and MI injury group compared to the control group. When these two were compared against each other, the need for bifurcations was higher in the AMI 4a group.

 

Conclusions

AMI type 4a was not associated with increased mortality at one year follow up, and it presented higher risk of recurrent AMI, as did MI injury. The higher number of stents, length of stents, bifurcations treatment and the use of rotational atherectomy were associated with higher AMI 4a and myocardial injury incidence.

 

Editorial Comment

There is a long history of interests and controversy around the definition of periprocedural infarction. What matters is whether it is associated with subsequent adverse outcomes, especially mortality.

 

Even though this article ─given its design and its sample size─ cannot provide categorical results, it provides encouraging information: a significant number of PCI patients (33% of the population) evolved with increased biomarkers that more often than not prolong hospitalization and even the need for new coronary angiograms justified only by troponin values that are more and more sensitive to diagnosis, and cannot be associated to mortality increase.

 

Courtesy of Dr. Brian Nazareth Donato.

Hospital Britanico de Buenos Aires, Argentina.

 

Original title: Type 4a myocardial infarction: incidence, risk factors, and long-term outcomes.

Reference  Catheterization and Cardiovascular Interventions DOI 10.1002/ccd.  Xiaoyu Yang, Hector Tamez, Carol Lai, Kalon Ho, and Donald Cutlip.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

CRABBIS Trial: Comparison of Different Provisional Stenting Sequences

Provisional stenting (PS) is the gold standard for percutaneous coronary intervention (PCI) in most patients with coronary bifurcation lesions (CBL). Moreover, recent studies such...

Andromeda Trial: Meta-Analysis of Drug Coated Balloon vs. DES in Small Vessel DeNovo Lesions

The use of coronary stents vs plain old balloon angioplasty (POBA), has allowed to reduce recoil and limiting flow dissection which were major limitation...

QFR vs. FFR: Is Coronary Revascularization Deferral Safe? Results from a FAVOR III Sub-Analysis

In cases of intermediate coronary lesions, functional assessment is recommended to aid the decision-making process regarding revascularization. There are several tools currently used to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACC 2025 | FAME 3: FFR Guided PCI vs CABG 5 Year Outcomes.

Earlier studies comparing percutaneous coronary intervention (PCI) vs coronary artery bypass graft (CABG) have shown fewer events at long term for the surgical strategy.  However,...

ACC 2025 | API-CAT: Reduced vs. Full Dose Extended Anticoagulation in Patients with Cancer Related VTE

The risk of cancer related recurrent venous thromboembolism (VTE) will drop over time, while bleeding risk will persist. At present, it is recommended we...

STRIDE: Semaglutide in Patients with Peripheral Arterial Disease and Type II Diabetes

Peripheral arterial disease (PAD) is a severe complication in patients with type II diabetes, primarily affecting peripheral vessels, especially below-the-knee (BTK) arteries. This condition...